| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11030814 | Journal of Molecular and Cellular Cardiology | 2018 | 36 Pages |
Abstract
Rivaroxaban (100-300â¯nmol/L) regulates atrial fibroblast activity and atrial fibrosis by increasing NO production and decreasing Ca2+ entry through inhibition of PAR signaling.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Cheng-Chih Chung, Yung-Kuo Lin, Yao-Chang Chen, Yu-Hsun Kao, Yung-Hsin Yeh, Yi-Jen Chen,